OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2024
(3)
2021
(3)
2020
(3)
2011
(3)
2018
(2)
2015
(2)
2023
(1)
2022
(1)
2019
(1)
2017
(1)
2016
(1)
2014
(1)
2012
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.
Not available
S-EPMC7445022
|
biostudies-literature
Cite
A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome.
Not available
S-EPMC9954109
|
biostudies-literature
Cite
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
Not available
S-EPMC6594622
|
biostudies-literature
Cite
Autologous Cell Seeding in Tracheal Tissue Engineering.
Not available
S-EPMC5683058
|
biostudies-literature
Cite
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial.
Not available
S-EPMC4465629
|
biostudies-literature
Cite
Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation.
Not available
S-EPMC8134060
|
biostudies-literature
Cite
Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with <sup>89</sup>Zr-oxine PET-CT.
Not available
S-EPMC7318529
|
biostudies-literature
Cite
Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.
Not available
S-EPMC4839369
|
biostudies-literature
Cite
Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy.
Not available
S-EPMC11261707
|
biostudies-literature
Cite
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
Not available
S-EPMC6232080
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets